OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Emilio Perucca
Journal of Epilepsy Research (2017) Vol. 7, Iss. 2, pp. 61-76
Open Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C Michael White
The Journal of Clinical Pharmacology (2019) Vol. 59, Iss. 7, pp. 923-934
Closed Access | Times Cited: 212

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco, Emilio Perucca
Drugs (2019) Vol. 79, Iss. 13, pp. 1435-1454
Closed Access | Times Cited: 147

Cannabis: a multifaceted plant with endless potentials
Eric Fordjour, Charles F. Manful, Albert Adu Sey, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 46

Cannabis for the Treatment of Epilepsy: an Update
Tyler E. Gaston, Jerzy P. Szaflarski
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 11
Closed Access | Times Cited: 135

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
Lyndsey L. Anderson, Nathan L. Absalom, Sarah V. Abelev, et al.
Epilepsia (2019) Vol. 60, Iss. 11, pp. 2224-2234
Open Access | Times Cited: 128

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés‐Montero, et al.
Molecular Brain (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 104

The Antimicrobial Activity of Cannabinoids
John A. Karas, Labell J. M. Wong, Olivia K. A. Paulin, et al.
Antibiotics (2020) Vol. 9, Iss. 7, pp. 406-406
Open Access | Times Cited: 99

The Past, Present and Future of Cannabis sativa Tissue Culture
Adrian S. Monthony, Serena R.G. Page, Mohsen Hesami, et al.
Plants (2021) Vol. 10, Iss. 1, pp. 185-185
Open Access | Times Cited: 93

An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine
Ivan Urits, Matthew Borchart, Morgan Hasegawa, et al.
Pain and Therapy (2019) Vol. 8, Iss. 1, pp. 41-51
Open Access | Times Cited: 91

The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith Cheung, Hassendrini N. Peiris, Geoff Wallace, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6079-6079
Open Access | Times Cited: 91

Cannabinoids in the Pathophysiology of Skin Inflammation
Cristian Scheau, Ioana Anca Bădărău, Livia-Gratiela Mihai, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 652-652
Open Access | Times Cited: 83

It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
Seyed Alireza Salami, Federico Martinelli, Antonio Giovino, et al.
Molecules (2020) Vol. 25, Iss. 18, pp. 4036-4036
Open Access | Times Cited: 71

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Serena Silvestro, Giovanni Schepici, Placido Bramanti, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5186-5186
Open Access | Times Cited: 71

Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research
Valentina Franco, Meir Bialer, Emilio Perucca
Neuropharmacology (2021) Vol. 185, pp. 108442-108442
Closed Access | Times Cited: 57

Review: Cannabinoids as Medicinals
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 38

Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
Eleonora Aronica, Nicola Specchio, Mark J. Luinenburg, et al.
Brain (2023) Vol. 146, Iss. 7, pp. 2694-2710
Open Access | Times Cited: 37

Cannabis for Chronic Pain: Mechanistic Insights and Therapeutic Challenges
Carla Matos, Ana Teresa Pereira, Maria João Dias, et al.
Stresses (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 1

Epilepsy and Cannabis: A Literature Review
Sidra Zaheer, Deepak Kumar, Muhammad Talha Khan, et al.
Cureus (2018)
Open Access | Times Cited: 77

Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview
Gian Mario Mandolini, Matteo Lazzaretti, Alessandro Pigoni, et al.
Epidemiology and Psychiatric Sciences (2018) Vol. 27, Iss. 4, pp. 327-335
Open Access | Times Cited: 73

Cannabis-based products for pediatric epilepsy: A systematic review
Jesse Elliott, Deirdre DeJean, Tammy Clifford, et al.
Epilepsia (2018) Vol. 60, Iss. 1, pp. 6-19
Open Access | Times Cited: 73

Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
Tomasz Dzierżanowski
Cancers (2019) Vol. 11, Iss. 2, pp. 129-129
Open Access | Times Cited: 72

Cannabinoids: from pot to lab
Esther Papaseit, Clara Pérez‐Mañá, Ana Pilar Pérez-Acevedo, et al.
International Journal of Medical Sciences (2018) Vol. 15, Iss. 12, pp. 1286-1295
Open Access | Times Cited: 71

Page 1 - Next Page

Scroll to top